Status:
UNKNOWN
Vitamin A Supplementation With Bacille Calmette Guerin (BCG) Vaccine
Lead Sponsor:
Bandim Health Project
Collaborating Sponsors:
March of Dimes
Leiden University Medical Center
Conditions:
Infant Mortality
Morbidity
Eligibility:
All Genders
Up to 5 years
Phase:
PHASE4
Brief Summary
In the present study the investigators wish to address the effects of different doses of vitamin A supplementation in low and normal birth weight infants. Hypotheses: * Vitamin A supplementation adm...
Detailed Description
Vitamin A deficiency is common in low-income countries. Vitamin A supplementation to children above 6 months of age reduces all-cause mortality by 23% to 30%. Studies on vitamin A supplementation in i...
Eligibility Criteria
Inclusion
- Normal birth weight: belonging to the study area
- Low birth weight: being born at the national hospital
Exclusion
- Overt illness
- Signs of vitamin A deficiency
- Previous BCG vaccination
Key Trial Info
Start Date :
November 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
7600 Patients enrolled
Trial Details
Trial ID
NCT00168610
Start Date
November 1 2004
Last Update
November 15 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Bandim Health Project, Apartado 861
Bissau, Guinea-Bissau